{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:23:16Z","timestamp":1793154196333,"version":"4.5.0"},"reference-count":24,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2009,9]]},"abstract":"<jats:p>Chronic autoimmune thyroiditis (ATD) frequently overlaps with autoimmune rheumatic diseases. The aim of this study was to evaluate the prevalence of various non\u2010organ\u2010specific autoantibodies in patients with ATD, as well as the presence of ATD in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). <jats:bold>Subjects and Methods:<\/jats:bold> Group 1 comprised 80 patients with ATD, and group 2 contained 80 patients with SLE or RA. A control group consisted of 34 healthy subjects. Group 1 was examined for the presence of non\u2010organ\u2010specific autoantibodies. Serum fT3, fT4, TSH, and antibodies against thyroglobulin, thyroperoxidase, as well as ultrasound of thyroid gland, were determined in group 2. <jats:bold>Results:<\/jats:bold> Patients with ATD had a significantly higher prevalence of antinuclear antibodies (ANA) than control subjects (45% vs. 14.7%, <jats:italic>P<\/jats:italic> &lt; 0.001). There were no significant differences in the prevalence of other antibodies between the groups. ANA\u2010positive patients were younger than ANA\u2010negative ones and had significantly higher anti\u2010TG values (<jats:italic>P<\/jats:italic> &lt; 0.05). The prevalence of ATD in group 2 was significantly higher than in the control subjects (24% vs. 8%, <jats:italic>P<\/jats:italic> &lt; 0.05). No significant differences in the prevalence of ATD were detected between SLE and RA. <jats:bold>Conclusion:<\/jats:bold> The authors conclude that ANA is the most frequent non\u2010organ\u2010specific antibody associated with ATD, while the other antibodies occur rarely. The prevalence of ATD in SLE and RA patients was 24%. These results indicate that it is clinically important to screen patients with SLE and RA for the coexistence of thyroid autoimmune disease.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2009.04809.x","type":"journal-article","created":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T22:02:36Z","timestamp":1251842556000},"page":"211-216","source":"Crossref","is-referenced-by-count":73,"title":["Autoimmune Thyroid Disease and Autoimmune Rheumatic Disorders"],"prefix":"10.1111","volume":"1173","author":[{"given":"Ivica","family":"Laz\u00farov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Benhatchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Rovensk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darina","family":"Koz\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedviga","family":"Wagnerov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1ria","family":"Tajt\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Macejova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,9]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/08916930500050194"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.02.006"},{"key":"e_1_2_8_4_2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1136\/ard.61.1.70","article-title":"Autoimmune thyroid disease in systemic lupus erythematosus","volume":"61","author":"Pyne D.","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-003-0803-5"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2004.11.004"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.022624"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb03927.x"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.4158\/EP.7.3.181"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.010058"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02238551"},{"key":"e_1_2_8_12_2","first-page":"479","article-title":"Thyroid involvement ion chronic inflammatory rheumatological disorders","volume":"13","author":"Bianchi G.","year":"1994","journal-title":"Clin. Rheumatol."},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-005-1165-y"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.4.1203"},{"key":"e_1_2_8_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055103"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-873005"},{"key":"e_1_2_8_17_2","first-page":"576","article-title":"Antinuclear antibody positivity in pediatric patients with autoimmune thyroid disease","volume":"24","author":"Inamo Y.","year":"1994","journal-title":"J. Rheumatol."},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2007.01.011"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb01844.x"},{"key":"e_1_2_8_20_2","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1515\/jpem-2008-210608","article-title":"Propyltiouracil associated antineutrophil cytoplsmatic antibodies (ANCA) in patients with childhood onset Graves\u2019 disease","volume":"21","author":"Panamonta O.","year":"2008","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/08916930701620100"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh531"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/41.2.180"},{"key":"e_1_2_8_24_2","first-page":"95","article-title":"Hashimoto's thyroidits and autoimmunity parameters: descriptive study","volume":"98","author":"Fiducia M.","year":"2007","journal-title":"Minerva Med."},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27302008000300014"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2009.04809.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2009.04809.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T07:41:46Z","timestamp":1695627706000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2009.04809.x"}},"subtitle":["A Two\u2010sided Analysis"],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["10.1111\/j.1749-6632.2009.04809.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2009.04809.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}